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INTRODUCTION
The hemidesmosome is a multimeric protein complex that
provides stable cell attachment to the underlying matrix of
epithelial cells (Borradori and Sonnenberg, 1999; Jones et al.,
1998). At the ultrastructure level, the hemidesmosome appears
as an electron dense structure whose cytoplasmic plaque serves
to anchor keratin-type intermediate filaments to the cell surface
(Borradori and Sonnenberg, 1999; Jones et al., 1998). A
number of components of the hemidesmosome have been
identified and these include at least two cytoskeleton linker
proteins, a 230 kDa human autoantigen termed BP230
(BPAG1) and plectin, as well as two transmembrane protein
complexes, the α6β4 integrin heterodimer and a second
human autoantigen called BP180 (BPAG2) (Borradori and
Sonnenberg, 1999; Jones et al., 1998; Klatte et al., 1989;
Rezniczek et al., 1998). 
BP180, also known as collagen XVII, was first identified
using sera of patients suffering from bullous pemphigoid, a
blistering skin disease (Giudice et al., 1992; Jones et al., 1998).
It is a type 2 transmembrane protein whose N-terminus resides
in the cytoplasmic plaque of the hemidesmosome (Hopkinson
et al., 1992). The extracellular domain of BP180 is composed
of a series of collagen-like repeats that are separated by linker
regions (Giudice et al., 1992; Li et al., 1993). Like other
collagens, BP180 exists as a trimer and it has now been
established that the extracellular domain of BP180 contributes
to the structure of anchoring filaments observed in the lamina
lucida of the basement membrane zone (Balding et al., 1997;
Bedane et al., 1997; Hirako et al., 1996). 
Evidence from analyses of the skin of patients suffering
from bullous pemphigoid and generalized atrophic
pidermolysis bullosa (GABEB), a genetic blistering skin
disease, indicate that BP180 plays an important role in
hemidesmosome assembly and adhesion of the epidermis to
the dermis (Borradori and Sonnenberg, 1999; Jonkman et al.,
1995). In bullous pemphigoid, autoantibodies against a non-
collagenous extracellular epitope in the BP180 molecule are
believed to be pathogenic and induce dysadhesion of the
epidermis (Giudice et al., 1993; Liu et al., 1993). Moreover,
epidermal cells in GABEB patients carrying mutations in the
gene that encodes for BP180 have a reduction in the number
of hemidesmosomes, leading to tissue instability (Borradori
and Sonnenberg, 1999; Jonkman et al., 1995). 
BP180 has multiple binding partners in the hemidesmosome.
The cytoplasmic domain of BP180 can interact with BP230
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Hemidesmosomes are multimeric protein complexes that
attach epithelial cells to their underlying matrix and serve
as cell surface anchorage sites for the keratin cytoskeleton.
Two hemidesmosome components, the α6β4 integrin
heterodimer and a human autoantigen termed BP180, are
transmembrane proteins that link the extracellular matrix
to the keratin network in cells. Here, we report that actinin-
4, an actin-bundling protein, is a potential binding partner
for BP180. Using yeast two-hybrid, we have mapped the
binding site for BP180 to the C-terminal region of actinin-
4. This site contains two EF-hand, Ca2+ regulation domains
and shares 87% sequence homology with the same region
in actinin-1. Consistent with this, BP180 can bind
actinin-1 in both the yeast two-hybrid assay and in
immunoprecipitation assays. To determine whether the EF-
hand domain is a consensus binding sequence for BP180,
we tested whether other proteins with this domain bind
BP180. None of the proteins tested including calmodulin,
with 4 EF-hand domains, and myosin regulatory light
chain, with 1 EF-hand domain, interacts with BP180 in
yeast two-hybrid system and immunoprecipitation studies,
suggesting that the interaction between BP180 and actinin
family members is specific. We have compared the
distribution of actinin-1 and actinin-4 with that of BP180
in MCF-10A and pp126 cells. Surprisingly, BP180 localizes
not only to sites of cell-substratum interaction, but is also
present at sites of cell-cell contacts where it co-distributes
with both actinin-1 and actinin-4 as well as other adherens
junction proteins. In oral tissues, BP180 is present along
the basement membrane and at cell-cell contact sites in
basal epithelial cells where it co-distributes with adherens
junction proteins. Since BP180 antibodies inhibit
association of junction proteins at sites of cell-cell contact
in oral keratinocytes, these results suggest that BP180 may
play a role in establishing cell-cell interactions. We discuss
a role for BP180 in crosstalk between cell-matrix and cell-
cell junctions.
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and the β4 integrin subunit, whereas the extracellular domain
can interact with the α6 integrin subunit (Aho and Uitto, 1998;
Borradori et al., 1997; Hopkinson et al., 1998; Hopkinson and
Jones, 2000). In this study, we focused our attention on
identifying novel binding partners of the cytoplasmic domain
of the BP180 molecule. Using yeast two-hybrid technology
we have identified actinins as binding partners of BP180.
This finding was surprising since BP180 had been thought
to be present exclusively at hemidesmosomes, where it
links to intermediate filaments. Conversely, the actinins are
microfilament-associated proteins that are found in adherens
junctions at sites of cell-cell interaction and in focal contacts
at sites where cells abut their substrate (Borradori and
Sonnenberg, 1999; Burridge and Chrzanowska-Wodnicka,
1996; Jones et al., 1998). However, in this study we show that
BP180 is not only found at sites of cell-substrate interaction
but also is concentrated at regions of cell-cell-contact, where
it co-distributes with and can interact with a number of
adherens junction proteins. Moreover, we present evidence that
BP180 is involved in establishment of intercellular junctions
and can play a role in cell-cell interactions.
MATERIALS AND METHODS
Cell culture and transfection procedure 
MCF-10A and pp126 cells were cultured as detailed previously
(Goldfinger et al., 1998). Cells were maintained for 72 hours on 22
mm glass coverslips. They were transfected with 4 µg of plasmid
DNA using the calcium phosphate protocol (Sambrook et al., 1989).
At 24 hours following transfection cells were harvested for
immunoblotting or processed for immunofluorescence microscopy
(see below).
Yeast two-hybrid assay
An MCF-10A cDNA library was prepared according to the Two-
Hybrid cDNA Library Construction Kit protocol (Clontech Labs Inc.,
Palo Alto, CA). cDNAs encoding portions of BP180, actinin family
members, calmodulin and α6-integrin were amplified using RT-PCR
from MCF10A mRNA using specific forward and reverse primers
containing engineered restriction sites. Murine myosin regulatory
light chain (MRLC) was a gift from Rex Chisholm (Northwestern
University). These fragments were digested with the appropriate
enzymes, isolated from an agarose gel using the QIAquick gel
extraction kit (Qiagen, Charworth, CA), and ligated in frame into
digested yeast expression vectors pACT2 or pAS2-1 (Clontech Labs
Inc., Palo Alto, CA). Individual clones containing these constructs
were grown in selective media and DNA prepared from the clones
using a Wizard mini prep kit (Promega, Madison, WI). All constructs
were sequenced to ensure that the cDNAs were in frame and without
error using Big Dye automated sequencing reagents (PE Applied
Biosystems, Foster City, CA) on an ABI Prism DNA Sequencer
(Foster City, CA). 
DNA preparations were used to transform the yeast strain Y190,
according to protocols outlined in the Matchmaker Two-Hybrid
System 2 Manual (Clontech Labs). Transfected colonies were selected
by growth in medium lacking leucine, tryptophan and histidine
(Leu–/Trp–/His–) but containing 25 mM 3-amino-1,2,4-triazole (3-
AT). The latter was used to inhibit low levels of ‘leaky’ expression of
His3p in the reporter yeast strain. To monitor transfection efficiency
of both plasmids, the transfected yeast were also plated onto Leu–
medium, Trp– medium or Leu–/Trp– medium. At 7 days the number
of colonies growing on both the Leu–/Trp– and Leu–/Trp–/His– media
were scored. Yeast colonies growing on both Leu–/Trp–/His– and
Leu–/Trp– media were also spotted onto nylon filters and flash frozen
in liquid nitrogen. To detect activation of the reporter gene lacZ and
resulting expression of β-galactosidase, the filters were placed on
Whatman paper soaked in a solution containing X-gal (5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside). A binding domain plasmid
(pVA3-1), containing a cDNA encoding murine p53, and an activation
domain plasmid (pTD1-1), containing the SV40 large T-antigen
coding sequence, were used as part of our control studies (Clontech
Labs).
Recombinant protein preparation 
The cytoplasmic domain of BP180 (residues 1-461), actinin-4
(residues 1-884), actinin-1 (residues 1-892) and MRLC (residues 1-
172) were prepared as 6× His-tagged recombinant fusion proteins in
E. coli. The relevant portion of BP180 was generated by RT-PCR
using MCF10A mRNA and the BP180 cDNA fragment was cloned
in frame into the pET 32 vector (Novagen, Madison, WI). This
construct was sequenced to confirm that the reading frame was
maintained and that the sequence was correct. E. coli were
transformed with the BP180 construct and were subsequently induced
to produce recombinant protein by the addition of isopropyl-β–D
thiogalactopyranoside (IPTG) to the medium. The cells were lysed
and extracts were incubated overnight in a 6 M urea buffer. Cell
extracts were passed over a His.B nd Resin column (Novagen,
Madison, WI) and bound fusion protein eluted in an imidazole elution
buffer in the presence of 6 M urea. The eluant was dialyzed against
10 mM Tris buffer (pH 7.5) overnight at 4°C, concentrated by
lyophilization and resuspended in sterile H2O. The purity of the
recombinant polypeptides was assessed by visualizing the protein
samples by SDS-PAGE and by Western blotting.
To generate HA-tagged proteins, actinin-4, actinin-1 and MRLC,
pACT2 constructs were used as DNA templates since the pACT2
vector contains a hemagglutinin sequence (HA) upstream of the
cloning site. Vector-specific forward and sequence-specific reverse
primers were used to generate cDNAs for actinin-4, actinin-1 and
MRLC containing the HA sequence at the 5′ end. The PCR products
were purified and cloned in frame into the pBAD-TOPO vector
(Invitrogen, Carlsbad, CA). Constructs were sequenced as described
above to ensure that sequences were correct and that inserts were in
frame. E. coli were transformed with appropriate constructs and
expression of recombinant protein was induced by adding 2%
arabinose to the medium for 3 hours at 37°C. Cells were lysed,
centrifuged and the supernatant was passed over a His Bind Resin
column (Novagen). Proteins were eluted in an imidazole elution
solution and eluates were dialyzed overnight and processed as
described above.
Green fluorescent protein (GFP) and HA-tagged
constructs
cDNA’s encoding full-length actinin-4 (residues 1-884) and truncated
actinin-4 (residues 1-813) with the HA tag incorporated at 5′ end,
were cloned into pCR3.1-Uni vector (Invitrogen). In addition, actinin-
4 cDNA cloned into the pEGFP-NI vector (Clontech) was used in
some transfection studies.
Antibodies
A mouse IgM monoclonal antibody (1804b) against the N-terminal
domain of BP180 was prepared as described (Hopkinson et al., 1992;
Riddelle et al., 1992). J17 rabbit antiserum was generated against the
same BP180 domain (Hopkinson et al., 1992). The rabbit C-terminal
antiserum generated against the C-terminal domain of BP180 was
obtained from Kim Yancey (NIH, Bethesda, MD). Monoclonal
antibody HA.11 against the HA epitope tag was obtained from
BAbCO. The actinin-4 polyclonal serum was a generous gift from
Setsuo Hirohashi (Honda et al., 1998). The mouse monoclonal
antibody against actinin-1 was purchased from Sigma Chemical Co.
The p120 antibody was obtained from BD Transduction Laboratories.
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The E-cadherin monoclonal antibody was generously provided by
Kathy Green (Northwestern University). 
Gel electrophoresis, immunoblotting and
immunoprecipitation 
Recombinant proteins, bacterial and mammalian cell extracts were
solubilized in sample buffer (8 M urea, 10% β-mercaptoethanol, 1%
SDS, 10% glycerol in 10 mM Tris-HCl, pH 6.8) and were subjected
to SDS-PAGE using 7.5-10% acrylamide gels (Laemmli, 1970). For
western immunoblotting, proteins separated on gels were transferred
to nitrocellulose membranes that were then processed with antibody
as described elsewhere (Harlow and Lane, 1988). S-tag peptide fusion
proteins were visualized with S protein conjugated to alkaline
phosphatase (Novagen).
For immunoprecipitation studies using recombinant proteins,
approximately 1 µg of actinin-4, actinin-1 or MRLC protein and
BP180 fragments were mixed together in 500 µl of 1×
‘immunoprecipitation buffer’ (25 mM Hepes pH 7.5, 1% Brij 97, 150
mM NaCl, 5 mM MgCl2, 0.2% SDS and protease inhibitors). After a
2 hour incubation at 4°C, J17 antiserum against BP180 was added
to a 1:100 dilution and incubated at 4°C for a further 2 hours.
Subsequently, 50 µl of protein G agarose (Gibco/BRL, Gaithersburg,
MD) were added to the mix for an additional 1 hour. The protein G
agarose was collected by centrifugation, washed four times in buffer
and then solubilized in sample buffer. The resulting protein solution
was processed for western immunoblotting as detailed above. 
In the case of pp126 cells, extracts were prepared using
immunoprecipitation buffer, which was then processed as described
above, with one exception, the extracts were passed through a 22
gauge needle prior to addition of antibody. 
Immunofluorescence microscopy
Cells, grown on glass coverslips, were fixed for 1 minute in 3.7%
formaldehyde and then extracted in 0.5% Triton X-100 at 4°C for
7 minutes. Single and double-label immunofluorescence were
performed as detailed previously (Riddelle et al., 1992). After
mounting, coverslips were viewed on a Zeiss LSM510 confocal
microscope, fitted with appropriate filters for visualization of GFP as
well as fluorescein and rhodamine-conjugated probes (Carl Zeiss,
Thornwood, NY). Controls for immunocytochemistry included
omission of primary antibodies or use of irrelevant immunoglobulin
(IgG) to determine non-specific binding of secondary antibodies.
Oral tissues were rapidly frozen in liquid nitrogen and cryosections
5-6 µm thick, were prepared on a Tissue-Trek cryostat (Miles
Laboratories Inc., Elkhart, IN). Sections were then placed on
microscope slides and fixed for 5 minutes in acetone at –20°C.
Samples were air-dried and processed for double-label
immunofluorescence as described above.
Antibody blocking assays
A polyclonal antibody against the C-terminal extracellular domain of
BP180 was added to pp126 cells maintained in low calcium medium
at a final concentration of 50 µg/ml for 24 hours. Rabbit IgG serum
was used as a control. Calcium from a 100X stock was added to each
dish to a final calcium concentration of 2.0 mM in the presence of
BP180 antibody or control IgG. After 4 hours, cells were processed
for immunofluorescence as described above. Rabbit IgG was
visualized using a fluorochrome-conjugated secondary anti-rabbit
goat antibody. 
RESULTS
BP180 interacts with actinin family members
In this study, it was our initial goal to use the yeast two-hybrid
technique to identify novel binding partners of the cytoplasmic
domain of the BP180 molecule. To do so, a library was
constructed using MCF10A cell cDNA cloned into a pGAD
vector containing the GAL4-activating domain. We chose
MCF-10A cells for this purpose since they express all of the
known components of hemidesmosomes and assemble mature
hemidesmosomes in vitro (Stahl et al., 1997). A BP180 cDNA
encoding amino acid residues 1-517, cloned into the pAS2-1
vector containing the GAL4 DNA binding domain, was used
as ‘bait’. 
The bait and the MCF-10A cDNA library were co-
transfected into the Y190 yeast strain and the transfected yeast
were plated onto restrictive media. Yeast colonies able to grow
on the media were analyzed further for β-galactosidase activity.
Approximately 20 clones that turn blue were characterized at
the molecular level. One such clone contained a cDNA insert
encoding residues 708-813 of an actinin isoform termed
actinin-4 (Honda et al., 1998) (Table 1). We decided to focus
on this clone because we were intrigued by the possibility that
BP180 might interact with the actin cytoskeleton. To confirm
that BP180 and actinin-4 specifically interact in the yeast two-
hybrid assay, we prepared an actinin-4 cDNA encoding the
same residues (703-813) by RT-PCR using mRNA prepared
from MCF-10A cells. This cDNA was cloned into a pACT2
yeast expression vector. Following co-transfection with a
pAS2-1 vector containing a BP180 cDNA, the transfected
yeast grow on restrictive medium and turn blue in the β-
galactosidase assay (Table 1). Control transfectants including
those co-expressing either actinin-4 or BP180 in combination
with α6 integrin, p53 or large T-antigen do not grow on
Leu–/Trp–/His– medium and fail to turn blue under the same
conditions (Table 1). 
Our yeast two-hybrid assay reveals that a fragment of 110
amino acids in the actinin-4 molecule can interact with the
cytoplasmic domain of BP180. This fragment contains two EF-
hand domains and shows considerable homology with other
actinin family members (Fig. 1). We therefore tested the
possibility that actinin-1, an actinin isoform expressed by
epithelial cells, can interact with BP180 (Otey et al., 1990). An
actinin-1 cDNA encoding residues 708-850 was generated by
RT-PCR using mRNA isolated from MCF-10A cells and
                 711                                  75 0
     ACT4  ( 703)  EHIRVGWEQLLTTI ARTINEVENQILTRDAKGISQEQMQE
     ACT1  ( 711 )  EHIRVGWEQLLTTI ARTINEVENQILTRDAKGISQEQMNE
      CaM    ( 1)  ---------------------------- MADQLTEEQI AE
     MRLC    ( 1)  ------- MSSKRAKTKTTKKRPQRATSNVFAMFDQSQI QE
Consensus   ( 711 )  EHIRVGWEQLLTTI ARTINEVENQILTRDAKGISQEQIQE
                 751                                  7 90
     ACT4  ( 743)  FRASFNHFDKDHGGALGPEEFKACLI SLGYDVENDRQGEA
     ACT1  ( 751 )  FRASFNHFDRDHSGTLGPEEFKACLI SLGYDIG NDPQGEA
      CaM   ( 13)  FKEAFSLFDKDGDGTI TTKELGTVMRSLGQN----- PTEA
     MRLC   (34)  FKEAFNMI DQNRDGFI DKEDLHDMLASMGKN------- P-
Consensus   ( 751 )  FKEAFNHFDKDHDGTIG PEELKACLISLG YNI  ND QGEA
                 7 91                          822
     ACT4  ( 783)  EFNRI MSLVDPNHSGLVTFQAFID FMSRETTD
     ACT1  ( 791)  EFARI MSI VDPNRLGVVTFQAFID FMSRETAD
      CaM   (4 8)  ELQDMI NEVDADGNGTID FPEFLTMMARKMKD
     MRLC   ( 66)  - TDEYLDAMMNEAPGPI NFTMFLTMFGEKLNG
Consensus   ( 791)  EFNRIMSIVDPNA GLI TFQAFI TMMSRKT D
Fig. 1. Amino acid comparison of actinin-4 and other EF-hand
proteins. The region in actinin-4 that interacts with BP180 is
conserved among actinin family members and contains two EF-hand
domains. The schematic includes a comparison of the BP180-binding
sequence in actinin-4 and the comparable EF-hand domains in
actinin-1, calmodulin and myosin regulatory light chain (MRLC).
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cloned into the pACT2 vector. Yeast co-transfected with this
actinin-1 construct and BP180/pAS2-1 grow in restrictive
media and turn blue in a β-galactosidase assay (Table 1). 
Because the region of actinins that shows interaction with
BP180 contains two EF-hand domains, we next evaluated the
possibility that the EF-hand domain possesses a consensus-
binding site for BP180. To do so, we
tested whether proteins that contain
different numbers of EF-hand
domains show interaction with
BP180 in the yeast two-hybrid
system (Table 1). We chose
calmodulin, which contains four
such domains, and myosin regulatory
light chain (MRLC) with one EF
hand domain for these assays.
Both calmodulin and MRLC were
cloned into the pACT2 vector
and transfected into yeast cells
containing the BP180/pAS2-1
construct. The co-transfectants are
unable to grow on restrictive media
and do not turn blue in the β-
galactosidase assay indicating that
there is no interaction between
BP180 and the EF-hand domains of
either calmodulin or MRLC (Table
1). 
To provide additional evidence for
interaction between actinin family
members and BP180, we prepared
recombinant proteins of full-length
actinin-4, actinin-1, MRLC and the
cytoplasmic fragment (residues 1-
461) of BP180 in bacteria. All
proteins were His-tagged and were
purified by column chromatography.
In addition to the His tag, the
recombinant actinin-4, actinin-1 and
MRLC were tagged with a
hemagglutinin (HA) epitope that is
recognized by monoclonal antibody
HA.11. The BP180 fragment was
fused to an S-tag peptide that binds ribonuclease S-protein. The
actinin-4, actinin-1 or MRLC and BP180 recombinant proteins
were mixed in Hepes-buffered saline containing a cocktail of
protease inhibitors. Proteins were precipitated by the addition
of a 1:100 dilution of antiserum J17, which was generated
against the N-terminus of BP180 (Hopkinson et al., 1992).
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Fig. 2. Immunoprecipitation studies indicate that BP180 can bind actinin-4 and actinin-1 but not
MRLC. Approximately 1 µg each of either HA-tagged actinin-4 (Ai), actinin-1 (Aii) or MRLC
(Aiii) were incubated with a purified S-tagged BP180 fusion polypeptide in Hepes-buffered saline
with 1% Brij 97 and 0.2% SDS at 4°C for 2 hours. As a control, tagged BP180 polypeptide was
omitted from the immunoprecipitation mixture (Ai-iii, lane 2). A polyclonal antiserum against the
BP180 cytoplasmic domain was added to the protein mixture for an additional 2 hours, followed
by the addition of protein G-agarose beads (Life Technologies/BRL). The precipitated proteins
were subjected to SDS-PAGE and transferred to nitrocellulose membrane. The blot was probed
either with HA.11 antibody directed against the HA tag (A) or an alkaline phosphatase-conjugated
S-protein that binds S-tag peptide fusion proteins (B). In lane 1 in Ai, the HA.11 antibody
recognizes a single polypeptide, indicating that actinin-4 has been precipitated with BP180.
Similar results were obtained when BP180 was precipitated from the BP180/actinin-1 mix (lane 1
in Aii). By contrast, MRLC was not precipitated from the MRLC/BP180 mix as indicated by the
absence of a band in lane 1 in Aiii. No protein is recognized by the HA.11 antibody in Ai-iii lane
2, indicating that actinin-4, actinin-1 or MRLC were not precipitated by the BP180 antiserum. The
enzyme-linked S-protein in B recognizes the immunoprecipitated BP180 polypeptide in Bi-iii lane
1. Molecular mass markers indicated on the left of the upper panels are as follows: from top to
bottom 172, 111, 79, 61, 49, 36 kDa. 
Table 1. Identification of positive clones by yeast two-hybrid
Plating efficiency on Leu–/Trp–/His–
Test pairs +25 mM 3-AT medium β-gal activity
BP1801-517pAS2-1/ACT4703-813pGAD +++ +++
BP1801-517pAS2-1/ACT4703-813pACT2 +++ +++
α6 Integrin full length pAS2-1/ACT4703-813pACT2 – –
p53 pAS2-1/ACT4703-813pACT2 – –
BP1801-517pAS2-1/ large T-antigen pACT2 – –
BP1801-517pAS2-1/ACT1708-850pACT2 +++ +++
p53 pAS2-1/ACT1708-850 pACT2 – –
BP1801-517pAS2-1/CaM pACT2 – –
BP1801-517pAS2-1/MRLC pACT2 – –
Yeasts transfected with the indicated yeast constructs were plated on both Leu–/Trp– and Leu–/Trp–/His– +25 mM 3-AT medium. Yeast were allowed to grow
for 7 days. Plating efficiency on Leu–/Trp–/His– +25 mM 3-AT medium is expressed relative to that on Leu–/ Trp– medium. +++ and – indicate plating
efficiencies of >50% and 0%, respectively. Colonies that grew on Leu–/Trp–/His– +25 mM 3-AT medium were transferred to nylon filters. These filters were then
placed on X-gal-soaked filters, and the ability of yeast to turn blue was assessed. In instances where there was no growth in Leu–/Trp–/His– +25 mM 3-AT
medium, colonies from Leu–/Trp– medium were analyzed. +++, colonies that turned blue within 6 hours of development; –, colonies that failed to turn blue
within this time period. Each pair was tested at least three times for plating efficiency on Leu–/Trp–/His– +25 mM 3-AT medium and in the β-galactosidase assay.
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Precipitated proteins were separated by SDS-PAGE, and
transferred to nitrocellulose. The filter was probed with HA.11
antibodies, which recognize the HA epitope on the actinin-4,
actinin-1 or MRLC polypeptides. Actinin-4 is co-precipitated
by the J17 antiserum when mixed with purified BP180
cytoplasmic domain but is not co-precipitated by J17
antibodies when incubated in the absence of BP180 protein
(Fig. 2Ai, compare lanes 1 and 2). Similar results were
obtained when actinin-1 was mixed with the BP180 fragment
(Fig. 2Aii). By contrast, MRLC is not co-precipitated by the
J17 antiserum when mixed with purified BP180 cytoplasmic
domain and is not co-precipitated by J17 antibody when
incubated in the absence of BP180 protein (Fig. 2Aiii). S-
protein binding was used to confirm successful precipitation of
BP180 polypeptide (Fig. 2B). 
Actinin-1 co-precipitates with BP180 from pp126
cells 
To provide evidence that BP180 and actinin family members
associate in vivo, we undertook immunoprecipitation studies
(Fig. 3). Extracts of pp126 oral keratinocyte cells were
prepared from cells maintained in medium containing reduced
levels of calcium or cells ‘switched’ to medium containing
2 mM calcium for 4 hours. Antibodies against BP180
specifically precipitate actinin-1 from extracts of cells
maintained in medium containing 2 mM calcium but fail to
precipitate actinin-1 from pp126 cells from cells grown in low
calcium medium (Fig. 3). By contrast, actinin-4 is not
precipitated by BP180 antibodies from extracts of pp126 cells
regardless of medium conditions (not shown).
Actinin family members co-distribute with BP180 at
sites of cell-cell contact 
Actinin-4, actinin-1 and BP180 fail to localize at regions of
cell-cell interaction in pp126 oral keratinocytes when the cells
are maintained in medium containing reduced levels of calcium
(Fig. 4). Actinin-4 shows concentration at the cell edges in
ruffled membranes while actinin-1 localizes to focal contacts
at the base of the cell and cortical microfilament arrays (Fig.
4A,B). By contrast, BP180 is found in streaks and arcs at the
basal surface of the cells (Fig. 4C). In pp126 cells that have
been ‘switched’ to medium containing 2 mM calcium for 4
hours prior to processing for immunofluorescence microscopic
observation, all three proteins appear at cell-cell contact sites
(Fig. 5). Moreover, in pp126 cells under these conditions
BP180 co-localizes with both actinin-4 as well as actinin-1 at
such sites (Fig. 5A-C and D-F, respectively). BP230 and
plectin, two hemidesmosome proteins, fail to localize at sites
of cell-cell contact in high calcium but instead distribute at the
basal aspect of cells where they adhere to substratum (not
shown). 
We have compared the localization of BP180 with both
actinin-1 and actinin-4 in a second epithelial cell line. In MCF-
10A cells, BP180 stains in arcs and streaks at the substratum
attached surface of the cells (Fig. 6B,E, long arrow). Along this
surface of the cell there is no obvious co-distribution of BP180
with either actinin-1 or actinin-4. However, BP180 also shows
concentration along regions of cell-cell contact consistent with
a previous report (Kitajima et al., 1994) (Fig. 6B,E, small
arrows). We observe such intercellular BP180 distribution with
two different antibody probes against the N-terminus of
BP180. Actinin-4 and actinin-1 also localize at sites of cell-
cell interaction and their distribution overlaps with that of
BP180 (Fig. 6A,B). This is most clearly seen in the overlays
Fig. 3.BP180 can co-precipitate actinin-1 from pp126 cells.
Extracts of pp126 cells were prepared from cells maintained in
medium containing low calcium (lanes 1,2) or cells which had been
switched into medium containing 2.0 mM calcium for 4 hours
(lanes 3,4). A polyclonal antiserum against the BP180 cytoplasmic
domain (J17) (lanes 1,3) was added to the cell extracts which were
incubated for 2 hours. No antiserum was included in the extracts
shown in lanes 2 and 4. Subsequently protein G-agarose beads were
added and, after an additional 2 hours, the beads collected.
Precipitated proteins were subjected to SDS-PAGE, transferred to
nitrocellulose membranes and processed for immunoblotting using
an actinin-1 monoclonal antibody (top). The same immunoblot was
then probed with the BP180 antiserum to ensure that BP180 protein
had been successfully precipitated (bottom). Note that actinin-1 at
100 kDa is precipitated with BP180 in lane 3 only. An unknown
protein recognized by the actinin-1 probe is indicated by an asterisk
in lanes 1 and 3 in the top panels. Molecular mass markers
indicated on the left of the upper panels are as follows: from top to
bottom: 172, 111, 79, 61 kDa.
Fig. 4. Sub-cellular distribution of actinin-4,
actinin-1 and BP180 in pp126 oral keratinocytes
maintained in low calcium medium. Cells were
processed for immunofluorescence microscopy
and labeled with antibodies against actinin-4
(A), actinin-1 (B) and BP180 (C). Actinin-4
localizes to the cell-edge in membrane ruffles in
A while actinin-1 is present in focal contact-like
structures and along the cortical microfilament
cytoskeleton in B. By contrast, BP180 localizes
along the basal aspect of the cell (C). Bars,
10µm.
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of the staining pattern where cell borders appear yellow where
BP180 co-distributes either with actinin-4 or actinin-1 (Fig. 6C
and F, respectively). 
Our immunofluorescence observations provide evidence that
actinin-1 and actinin-4 are found at the cell surface in two
distinct epithelial cell populations (Fig. 4; Fig. 6). By contrast,
workers in a previous study suggested that actinin-4 localizes
exclusively to the nucleus in certain breast epithelial cells
(Honda et al., 1998). Thus to resolve these conflicting results
we transfected MCF-10A cells with an expression vector
encoding GFP-tagged actinin-4. The product of the transgene
localizes to sites of cell-cell interaction on the surface of the
transfected cells (Fig. 7A). We see little, if any,
protein in the nucleus. To rule out the possibility
that the GFP tag influences the localization of
actinin-4, we also transfected MCF-10A cells
with HA-tagged actinin-4 (Fig. 7C). The
expressed fusion protein targets to the cell
surface rather than the nucleus. Interestingly, we
have observed only nuclear localization of
actinin-4 when we induce expression of a
truncated HA-tagged actinin-4 cDNA
encompassing residues 1-813 in MCF-10A cells
(Fig. 7E). 
Our finding that under certain circumstances,
BP180 is present at sites of cell-cell contact,
where it associates with adherens junction
proteins, is consistent with a study in which it
was shown using yeast two-hybrid technology
that BP180 can bind the adherens junction
protein p120 catenin (Aho et al., 1999). The
latter workers, however, provided no evidence
for such an association at the morphological
level. Thus to extend their observation we
prepared both MCF-10A and pp126 cells for
double-label immunofluorescence microscopy
using antibodies against the N-terminal domain
of BP180 and monoclonal antibodies against
p120 catenin (Fig. 8). These antibody
preparations generate overlapping staining
patterns at cell-cell contact sites in both cell
types (Fig. 8). The overlay images in Fig. 8C,F
show yellow staining where cells contact each other. In the case
of the pp126 cells, the cells were switched from their normal
medium to medium containing 2 mM calcium for 4 hours
before the cells were fixed and processed for
immunofluorescence in order to allow cells to establish cell-
cell junctions. Moreover, we also processed oral tissues for
double-labeling with antibodies that recognize BP180 and
p120 catenin. Antibodies against BP180 produced intense
staining along the basement membrane of oral epithelia. p120
catenin was absent from these sites (Fig. 9, arrow). However,
BP180 was also present at cell-cell borders where it co-
distributed with p120 catenin (Fig. 9, arrowhead). Similar
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Fig. 5. Increasing the concentration of calcium ions in
the medium induces co-localization of BP180,
actinin-4 and actinin-1 at cell-cell contact sites in
pp126 oral keratinocytes. pp126 oral keratinocytes
were ‘switched’ to medium containing 2.0 mM
calcium for 4 hours and then were processed for
double-label indirect immunofluorescence microscopy
using a combination of antibodies against actinin-4
and BP180 (A,B) or actinin-1 and BP180 (D,E). Both
actinins and BP180 co-distribute at cell-cell contact
sites (arrows in A-E). The overlapping staining
patterns appear yellow in the overlays (C,F). Bar,
10µm.
Fig. 6.BP180 co-distributes with actinin-4 and actinin-1 at cell-cell contact sites in
MCF-10A cells. MCF-10A cells were processed for double-labeling using antibodies
against either actinin-4 (A) or actinin-1 (D) in combination with an antibody
preparation against BP180 (B,E). BP180 co-localizes with actinin-4 at sites of cell-
cell contact (arrows in A,B). This appears yellow in the overlay of these images (C).
Actinin-1 and BP180 also co-distribute at cell-cell contact sites (arrows in D,E). The
areas of co-localization appear yellow in the overlay of the images (F). There is no
obvious actinin-4 or actinin-1 where BP180 is found along sites of cell-substrate
interaction (B,E, long arrows). Bar, 10 µm.
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observations were obtained with actinin probes (data not
shown). 
Does BP180 play a role in cell-cell interactions? 
Our studies demonstrate that BP180 is present in cell-cell
contacts and we next wished to determine whether BP180
plays a functional role at such sites. Thus we made use of an
antibody that recognizes the extracellular domain of BP180 in
an attempt to block BP180’s function. pp126 cells maintained
in low calcium were pretreated with a C-terminal antibody
against BP180. After 24 hours, cells were switched to high
calcium for 4 hours and labeled with either p120 catenin or
E-cadherin monoclonal antibodies as markers of adherens
junctions. In untreated cells and cells treated with control
immunoglobulin, p120 catenin and E-cadherin have a sharp,
linear distribution along borders of contacting cells (Fig.
10A,B, arrow). By contrast, p120 catenin fails to show the
same pattern in cells that were treated with the C-terminal
antibody against BP180 (Fig. 10C, arrow). Rather, in BP180
antibody treated cells, p120 catenin is organized in arrays that
are perpendicular to cell-cell contact sites. In BP180 antibody
treated cells, E-cadherin is diffusely localized (Fig. 10E). 
DISCUSSION
BP180 is a major structural element of hemidesmosomes
where it associates with not only the α6β4 integrin heterodimer
but also the BP230 component of the hemidesmosome plaque
(Borradori and Sonnenberg, 1999; Jones et al., 1998;
Hopkinson and Jones, 2000). BP180 mediates keratin
cytoskeleton association with the cell surface in epithelial cells
via such interactions (Borradori and Sonnenberg, 1999; Jones,
et al., 1998; Hopkinson and Jones, 2000). Therefore, it was a
surprise that during the course of the present studies we
identified two microfilament associated proteins, namely
actinin-1 and actinin-4, as binding partners of BP180.
Nonetheless, our immunochemical studies clearly support the
idea that BP180 and actinin family members show association
in vivo. Indeed, we have observed overlapping staining patterns
of antibodies against BP180 and actinin family members at
sites of cell-cell contact in two quite different epithelial cells
Fig. 7.The fate of the product of actinin-4 transgenes in transfected
MCF-10A cells. MCF-10A cells were transfected with constructs
expressing full-length actinin-4 fused with a GFP-tag (A) or an HA-
tag (C). In E, cells were transfected with a truncated actinin-4
(residues 1-813). At 24 hours after transfection, cells were processed
for immunofluorescence microscopy. HA.11 antibody was used to
visualize HA-tagged actinin-4 in transfected cells in C,E. Full-length
actinin-4 is absent from the nucleus but instead distributes to sites of
cell-cell contact as well as in the cytoplasm (arrows in A,C). By
contrast, truncated actinin-4 localizes exclusively to the nucleus (E).
B, D and F show phase contrast images of the cells. Bar, 10 µm.
Fig. 8.BP180 co-distributes with p120 catenin
in MCF-10A cells and pp126 oral
keratinocytes. The localization of p120 catenin
and BP180 proteins was assessed in MCF-10A
cells and pp126 oral keratinocytes maintained
in 2.0 mM calcium for 4 hours. Cells were
processed for double-label indirect
immunofluorescence microscopy using
antibodies against p120 catenin (A,D) and
BP180 (B,E). p120 catenin is present at cell-
cell interaction sites in both cell types (short
arrows in A,D) where it co-distributes with
BP180 (short arrows in B,E). This is
demonstrated by the yellow color in the
overlays in C and F. Although BP180
antibodies also stain along the basal aspect of
MCF-10A cells (long arrow in B) and in pp126
cells (long arrow in E), p120 catenin is absent
from these sites (A,D). Bar, 10 µm.
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types, namely the oral keratinocyte line pp126 and the
mammary epithelial cell line MCF-10A, as well as in oral
epithelial tissue. This is not the first time that the existence of
BP180 at cell-cell binding sites has been reported. In particular,
Kitajima et al. showed that in keratinocytes the localization of
BP180 can be modulated by the concentration of calcium of
the medium in which the cells are maintained (Kitajima et al.,
1994). We have confirmed and extended this observation. In
medium containing low levels of calcium, under which
conditions keratinocytes fail to make extensive cell-cell
contacts, BP180 localizes at the basal aspect of the cell at cell-
matrix contact sites. Both actinin-1 and actinin-4 fail to co-
distribute with BP180 at these sites. These morphological
observations are supported by immunoprecipitation studies
since BP180 antibodies fail to precipitate actinins from extracts
of such cells. However, upon ‘switching’ the cells to medium
containing calcium levels of 2 mM, cell-cell junctions form
with BP180 distributing to these sites along with actinin-1 and
actinin-4 and to regions of cell-matrix interaction that lack any
apparent actinin. Moreover, BP180 antibodies precipitate
actinin-1 from extracts of the switched cells. That actinin-4 is
not precipitated under these conditions suggests that actinin-1
may be the preferred BP180 binding partner in vivo. 
One surprise of our study was that actinin-4, like actinin-1,
is present at cell-cell contact sites both in MCF-10A cells and
the ‘switched’ oral keratinocytes. This finding is inconsistent
with a previous study by Honda et al. in which it was reported
that actinin-4 is a nuclear protein (Honda et al., 1998). To
address this apparent discrepancy we expressed full-length
actinin-4 in our epithelial cell populations. This confirmed our
antibody labeling experiments in that the protein product of the
actinin-4 transgene primarily targets to the cell surface and is
absent from the nucleus. 
Interestingly, as part of our analyses of actinin-4 distribution
in various cells, we discovered that a truncated version of
actinin-4 lacking the last 71 amino acids at the C-terminus of
the molecule localizes exclusively to the nucleus. In light of
these observations, we suggest that certain cancer cells,
including those in which actinin-4 was first described, may
process actinin-4, causing it to move to the nucleus (Honda et
al., 1998). This would explain the localization data presented
by the later study, although, to date, we have been unable to
confirm that cancer cells express such a truncated actinin-4
molecule (data not shown). 
One question that our study clearly raises relates to why
BP180 is found at sites of cell-cell interaction. One possibility
is that BP180 molecules at cell-cell borders may be in transit
to the basal surface of cells where they become incorporated
into hemidesmosomes. In this scenario, the association of
BP180 with microfilament-associated protein at lateral cell
surfaces may reflect the involvement of cellular motility
machinery in BP180 movement between cell membrane
domains following its synthesis and processing. At lateral cell
surfaces, actinins may provide part of an anchorage site or act
as a ‘sink’ for newly synthesized BP180 protein. In other
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Fig. 9.BP180 co-distributes with p120 catenin, at sites of cell-cell
contact in oral tissue. Tissues were processed for double-label
indirect immunofluorescence microscopy using antibodies against
BP180 (in red) and p120 catenin (in green). The overlay of the
images generated is shown. The area indicated by the arrows toward
the left-hand corner of the micrograph is shown at higher power in
the inset. BP180 distributes along the basement membrane (arrow)
and along lateral surfaces of basal oral epithelial cells (arrow head)
where it co-distributes with p120 catenin as demonstrated by the
yellow color. Bars, 20 µm.
Fig. 10.BP180 modulates establishment of cell-cell junctions. pp126
cells maintained in low calcium medium were treated with either
control IgG or an antibody against the C-terminus of BP180 for 24
hours and then switched to medium containing 2.0 mM calcium.
After 4 hours, cells were processed for confocal immunofluorescence
microscopy using an antibody against p120 catenin (A,C) or E-
cadherin (B,E) together with a secondary antibody to identify bound
BP180 antibodies (D,F). In cells treated with control IgG, p120
catenin and E-cadherin staining is linear and is concentrated along
sites of cell-cell contact (A,B). In cells treated with the BP180
antibody, p120 catenin appears in a punctate pattern in rows
perpendicular to cell-cell contact sites (C), whereas E-cadherin
shows a diffuse staining over the cell surface (E). D and F show that
BP180 antibodies bind at cell-cell contact sites. Bar, 10 µm.
4205BP180 and actinins
words, actinins may be playing a role as general scaffolding
proteins for molecules such as BP180, as previously suggested
(Parast et al., 2000). 
We also speculate that p120 catenin may play an important
role in the mechanism via which BP180 becomes directed to
lateral cell surfaces. Previous workers have provided evidence
from a yeast two-hybrid screen that BP180 and p120 catenin
interact (Aho et al., 1999). Here we show that p120 catenin and
BP180 co-distribute at cell-cell contact sites. Since p120
catenin binds to BP180 at a domain that is necessary for the
targeting of BP180 to hemidesmosomes, we propose that by
binding to BP180, p120 catenin inhibits BP180 incorporation
into hemidesmosomes and, together with the actinins, tethers
BP180 at cell borders. However, if this is the case, this is not
a generalized phenomenon for hemidesmosomal proteins since
BP230 or plectin, two cytoplasmic proteins of the
hemidesmosomal plaque, are not found at sites of cell-cell
contact in pp126 cells that are maintained in medium
containing 2.0 mM calcium under which conditions cells
assemble extensive intracellular junctions (not shown). Instead,
both plectin and BP230 remain concentrated at sites of cell-
substratum interaction in such cells. 
Of course, in addition to transiting through lateral cell
surfaces, BP180 may actually contribute to the structure and/or
stability of cell-cell interactions. There is certainly precedent
for this from the studies of other transmembrane, collagen-
related proteins. For example, collagen type XIII, which, like
BP180, is oriented with a type 2 topography in the plasma
membrane, is believed to play a role in stabilizing cell-cell
junctions (Hagg et al., 1998; Peltonen et al., 1999; Snellman
et al., 2000). Moreover, there is evidence that three other type
2 membrane proteins that possess collagen-like extracellular
domains, namely, the type 1 macrophage scavenger protein
receptor (MSPR), MARCO (a macrophage receptor with
collagenous structure) and ectodysplasin are involved in cell-
cell binding (Elomaa et al., 1995; Ezer et al., 1999; Kodama et
al., 1990). In particular, MSPR and MARCO mediate cell-
bacterial interactions whereas ectodysplasin appears to
distribute along cell-cell contact sites, where it interacts with
the microfilament cytoskeleton (Elomaa et al., 1995; Ezer et
al., 1999; Kodama et al., 1990). Indeed, in the studies we
present here we provide evidence that BP180 plays an active
role in establishing cell-cell interactions. In particular, an
antibody against the C-terminal domain of BP180 appears to
inhibit incorporation of adherens junction proteins into
assembling junctional complexes. 
In summary, we have identified new potential binding
partners of a major structural protein of the hemidesmosome.
That these partners are members of a family of actin binding
proteins that fail to localize to hemidesmosomes provides an
indication that BP180 is somewhat promiscuous with regard
to its cytoskeleton connections. Remarkably, this mirrors the
apparent promiscuity of the α6β4 integrin heterodimer which,
in the hemidesmosome, is involved in tethering the keratin
cytoskeleton to the cell surface whereas, in certain cancer
cells, it associates with the microfilament cytoskeleton
network (Rabinovitz and Mercurio, 1997). Indeed, BP180 is
one of an increasing number of proteins whose cytoskeleton
allegiance may be modulated in quite a precise fashion and
that may play a role in crosstalk of cell-matrix and cell-cell
junctions. 
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